The above summary is based on TTV’s Global Export Import data of paediatric co trimoxazole, compiled from 180+ countries export import shipments updated till .
HS-Code
Products
300420200000
PAEDIATRIC CO-TRIMOXAZOLE TABLETS BP 120MG (3600 X 1000) - JAR
300420200000
PAEDIATRIC CO-TRIMOXAZOLE TABLETS BP 120MG (750 X 1000) - JAR
300420200000
PAEDIATRIC CO-TRIMOXAZOLE TABLETS BP 120MG (400 X 1000) - JAR
HS-Code
Products
300420200000
PAEDIATRIC CO-TRIMOXAZOLE FOR ORAL SUSPENSION (240MG/5ML)( FORTRIM )(BATCH NO.D-060622 D-070622 D-080622 D-090622)(
300420200000
PAEDIATRIC CO-TRIMOXAZOLE FOR ORAL SUSPENSION (240MG/5ML) ( FORTRIM )(BATCH NO.D-020822 TO D-080822 D-010922 TO D-040
300420200000
PAEDIATRIC CO-TRIMOXAZOLE FOR ORAL SUSPENSION 240MG/5ML FORTRIM 10000X100ML(MLT)
HS-Code
Products
300490990000
PHILCO- COTRI - 240 (PAEDIATRIC CO-TRIMOXAZOLE ORAL SUSPENSION BP 240MG/5ML ) 100 ML BT 2111063-3 MFG 01/2022 EXP 12/202
300490990000
PHILCO-COTRI-240 (PAEDIATRIC CO-TRIMOXAZOLE ORAL SUSPENSION BP 240MG/5ML)100ML:B/NO.2102015-2 2102015-3
300490990000
PHILCO-COTRI-240(PAEDIATRIC CO-TRIMOXAZOLE ORAL SUSPENSION BP 240MG/5ML)100 ML:B/NO.2102015-1 M/D 04/2021 E/D 03/2024
HS-Code
Products
300420200000
PAEDIATRIC CO - TRIMOXAZOLE ORAL SUSPENSION (240MG/5ML) (FORTRIM) (BATCH NO. BEL-230601 BEL-231001)(8000 X 100ML )
300420200000
FORTRIM / PAEDIATRIC CO-TRIMOXAZOLE FOR
300420200000
PAEDIATRIC CO - TRIMOXAZOLE ORAL SUSPENSION (240MG/5ML) (FORTRIM) (BATCH NO. BEL-230601 BEL-231001)(8000 X 100ML )
Country | Trade Type | ||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
INDIA | Export Data | ||||||||||||||||||||||
| |||||||||||||||||||||||
UNITED STATES OF AMERICA | Import Data | ||||||||||||||||||||||
| |||||||||||||||||||||||
PAKISTAN | Import Data | ||||||||||||||||||||||
|
PAPUA NEW GUINEA | Import Data | ||||||||||||||||||||||
| |||||||||||||||||||||||
NETHERLANDS | Import Data | ||||||||||||||||||||||
| |||||||||||||||||||||||
UNITED STATES OF AMERICA | Import Data | ||||||||||||||||||||||
|